Thursday March 28th
Cornell O.C. Business Luncheon at the Center Club:
“10,000 Jobs by 2020”
We are privileged to have as our guest speaker Cornellian and Life Sciences Expert:
Matt Jenusaitis
President and CEO,
OCTANe
Date: Thusday, March 28th, 2013
Time: 11:30 am to 1:30 pm
Location: The Center Club
650 Town Center Drive – Garden Level,
Costa Mesa, CA 92626
Tel. (714) 662-3414
11:30 AM Luncheon will begin promptly
12:00 PM Presentation/Q&A
1:30 PM Luncheon will end promptly
Cost: $40/person Members
$45 for Non-members
includes valet parking at Center Club
Event Contact: Gaye Tomlinson, MBA ’05, CAAOC Business Lunches and Breakfasts, This email address is being protected from spambots. You need JavaScript enabled to view it. , 714-742-2948.
Event Summary:
In our first Luncheon of 2013, our guest Matthew Jenusaitis, President and CEO of OCTANe, answers a fundamental question: How do you take something that is inherently qualitative and arguably subjective and turn it into something quantitative - like creating companies and jobs. Matthew, who is a graduate of Cornell University’s School of Chemical Engineering, has built a successful career in the life science industries building new products and companies. In 2009 he became the CEO of OCTANe, a non-profit organization whose mission is to connect people and ideas with capital and resources to fuel technology growth in Orange County. Since then he has worked diligently to apply engineering fundamentals to a process that is inherently subjective - securing early stage funding for start-up companies in Orange County. He spearheaded OCTANe's LaunchPad program, which is co-sponsored by the US Small Business Association (SBA) and their Orange County Affiliate the Small Business Development Corporation (SBDC). With LaunchPad’s help, more than 82 companies have raised in excess of $172,000,000 in Seed, Series A, and Series B investments.
In the past two years, LaunchPad companies have created more than a thousand new jobs in Orange County and their current campaign, 10,000 jobs by 2020, is squarely focused on accelerating their progress.
Matthew will describe the process that they use, explain why they have had such tremendous success, and highlight several of the Orange County companies that have benefited and others that have failed.
Speaker Bio:
Matthew Jenusaitis is the President and CEO of OCTANe, an Orange County, CA non-profit organization focused on connecting people and ideas with capital and resources to fuel high technology innovation and economic development. OCTANe has assisted more than 110 companies raise more than $340 Million in early stage capital building the high technology ecosystem in Southern California.
Matthew is an experienced medical device industry professional with more than 25 years of engineering, sales and marketing, and executive level general management experience.
Matthew spent 15 years at Boston Scientific Corp., where he served in numerous executive marketing and general management positions. His most recent position with Boston Scientific was as the president of the $600 Million Peripheral Interventions Division (formerly Medi-Tech) leading the acquisition and integration of Cryovascular Systems, Inc. and EndoTex, Inc..
Prior to Peripheral Interventions, Matthew led the integration of Interventional Technologies increasing their annual revenues from $25 Million in 2001 to more than $150 Million in 2003. Before that, he held executive marketing and marketing management positions in the Microvasive Endoscopy, Boston Scientific International, and Scimed Life Sciences divisions.
Matthew was also an executive in residence for the private equity firm Warburg Pincus, LLC. This led to Matthew assuming the role of President of ev3 Neurovasuclar, one of Warburg’s portfolio companies. During his career, Matthew also spent 8 years at Baxter healthcare in both marketing and engineering management positions.
Matthew sits on the board of directors of Avantis Medical in Sunnyvale, CA, a visualization technology company focused on delivering cost effective solutions for the improved detection and prevention of cancer in the gastrointestinal (GI) tract. He is also a board member for Creagh Medical in Galway, Ireland, a developer and manufacturer of specialty angioplasty balloons, and Precision Wire Manufacturing in Portland, OR, and OEM supplier of high performance wires used in the medical device business.
He sits on the advisory boards for Cornell’s School of Biomedical Engineering, Chapman University’s Schmid School of Science and Technology, and the Claremont College’s Keck Graduate Institute of Applied Life Sciences.
Jenusaitis holds a bachelor of science in chemical engineering cum laude from Cornell University, a master of science in bio-chemical engineering from Arizona State University and a master of business administration from University of California, Irvine.